NCT01781975View on ClinicalTrials.gov

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2018

Conditions
Diabetes Mellitus, Type IDiabetes Mellitus, Insulin-Dependent, 1Type 1 Diabetes MellitusInsulin-Dependent Diabetes Mellitus 1IDDM
Interventions
DRUG

Imatinib Mesylate

DRUG

Placebo (For imatinib mesylate)

Trial Locations (9)

3050

Walter and Eliza Hall Institute of Medical Research, Melbourne

19104

Children's Hospital of Philadelphia, Philadelphia

30322

Emory University, Atlanta

46202

Indiana University, Indianapolis

52242

University of Iowa, Iowa City

75390

University of Texas Southwestern, Dallas

80045

Barbara Davis Center, Aurora

94143

University of California-San Francisco, San Francisco

02215

Joslin Diabetes Center, Boston

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University of California, San Francisco

OTHER